Actively Recruiting
Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN
Led by Women's Hospital School Of Medicine Zhejiang University · Updated on 2025-02-05
112
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective observational cohort study was designed. 1. Comparing of the clinical indicators between the hemolytic group and the non-hemolytic group,such as End-tidal carbon monoxide corrected for ambient CO(ETCOc),direct antiglobulin test(DAT), the highest total serum bilirubin level and hemoglobin. To explore the role of ETCOc in the diagnosis of neonatal ABO hemolytic disease. 2. Comparing of the clinical indicators between the neonates with IVIG treatment and the neonates without IVIG treatment in ABO hemolytic disease, such as ETCOc,total serum bilirubin level before IVIG treatment and ETCOc,total serum bilirubin level after IVIG treatment.To explore the clinical value of ETCOc in the treatment of ABO hemolytic disease.
CONDITIONS
Official Title
Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Gestational age between 35 weeks 0 days and 41 weeks 6 days
- Birth weight at least 2500 grams
- Respiratory rate less than 60 breaths per minute
- Neonates admitted for phototherapy due to hyperbilirubinemia following expert guidelines (2014, China)
- ABO blood group incompatibility between mother and newborn
- Informed consent obtained
You will not qualify if you...
- Persistent difficulty breathing or need for respiratory support
- Skin damage or structural deformity around the nasal cavity
- Receiving intensive care treatment in the neonatal intensive care unit (NICU)
- Severe congenital malformations, chromosomal, or genetic abnormalities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Women's hospital School of medicine Zhejiang University
Hangzhou, China
Actively Recruiting
Research Team
Y
Yingying Bao, M.M.
CONTACT
C
Chuncai Xu, M.M.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here